Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
Hallucinogen |
| gptkbp:category |
recreational drug
tryptamine |
| gptkbp:chemicalFormula |
C13H18N2O
|
| gptkbp:discoveredBy |
gptkb:David_E._Nichols
|
| gptkbp:effect |
serotonin receptor agonist
|
| https://www.w3.org/2000/01/rdf-schema#label |
4P-PDOT
|
| gptkbp:IUPACName |
1-(4-propoxyphenyl)-2,3-dihydro-1H-indole-5-ethanamine
|
| gptkbp:legalStatus |
uncontrolled (in most countries)
|
| gptkbp:molecularWeight |
214.3 g/mol
|
| gptkbp:relatedTo |
gptkb:2C-T-7
gptkb:2C-B gptkb:2C-I |
| gptkbp:structure |
tryptamine backbone with 4-propoxy substitution
|
| gptkbp:studiedBy |
psychedelic effects
serotonin receptor selectivity |
| gptkbp:bfsParent |
gptkb:MT2_receptor
|
| gptkbp:bfsLayer |
7
|